
Clinical cancer genomic profiling

1. Introduction, abstract, Balancing regulation and innovation, Conclusion and perspectives: 
2. DNA mutations as biomarkers of therapy response
3. Integration of somatic and germline profiling
4. Alternatives to panel-based tumour NGS
5. Allelic configuration and mutational signatures
6. Powerpoint

hello Sep 2nd

Hello universe!!

I know you will.
